Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 574, Medicare Physician Payment Innovation Act
H.R. 1427, Truth in Healthcare Marketing Act of 2013
H.R. 1331, Electronic Health Records Improvement Act

H.R. 351, Protecting Seniors' Access to Medicare Act; IPAB

S.351, Protecting Seniors' Access to Medicare Act; IPAB

Budget Control Act of 2011: P.L. 112-25

Anesthesia Rural Pass Through

Reform of the Medicare Sustainable Growth Rate - House Energy & Commerce and Ways & Means proposal

Historical Medicare payment undervaluation for anesthesiology services (33% problem)

Anesthesia Conversion Factor

Perioperative Surgical Home Model

Medicare Reform, Payment Issues: Medicare Sustainable Growth Rate repeal

Bundled payments

CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services

2013 Medicare Payment Rule - Revisions to payment policies under the Physician Fee Schedule - Chronic Pain/CRNA Scope of Benefit














CMS Value-Based purchasing

CMS Medicare Data Final Rule

CMS Proposed Rule on Sunshine Act

CMS Reporting and Returning of Overpayments

Conditions of Participation - Anesthesia services, opt-outs, supervision

Physician Quality Reporting System, PPACA, Sec. 3007 Quality Modifier implementation

President Obama's deficit reduction plans, IPAB cuts

MedPAC nominations

Accountable Care Organizations

Graduate Medical Education Cuts

Medicare Local Coverage Determinations

HHS Plan for Retrospective Review of Existing Rules 2011 - Conditions of Participation

Value-based modifier - PPACA

Debt ceiling- Medicare sequestration

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Government Accountability Office (GAO)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 1427, Truth in Healthcare Marketing Act of 2013
P.L. 112-144, The Food and Drug Administration Safety and Innovation Act

Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee

PPACA Nondiscrimination language regarding paraprofessionals - repeal

DEA Scheduling Propofol

Comparative Effectiveness Research

HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use

HHS/OIG Anesthesia Practice Arrangements, Company Model

FDA Risk Evaluation and Mitigation Strategies

FDA Safe Use Initiative

Pain Management

Individual Mandate- PPACA

Proposed Federal CME requirements by ONDCP

FTC Letters to States regarding Interventional Pain Medicine and Advanced Practice Nurses













Scope of Practice

FDA Operating Room Fires

Prescription Drug User Fee Act

State Exchanges pursuant to PPACA

FDA SEDASYS

FDA Patient Prescriber working group

FDA Sedation Initiative

FDA Naloxone workshop

FDA Patient Prescriber Agreement workshop

FDA Anesthesia Trials workshop

FDA Opioid Efficacy workshop

ICD-10-CM/PCS and proposed delay of implementation date

FDA Opioid Labeling

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Justice - Dept of (DOJ), Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), Office of Management & Budget (OMB), Executive Office of the President (EOP), Defense - Dept of (DOD), Occupational Safety & Health Administration (OSHA), Federal Trade Commission (FTC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization